Iman Farahani

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB‐inhibitor‐induced phenotypes (2025)

FEBS Journal

Vaparanta, Katri; Song, Zejia; Farahani, Iman; Jokilammi, Anne; Merilahti, Johannes; Örling, Johanna; Virtanen, Noora; Haapaniemi, Pekka; Sahlgren, Cecilia; Elenius, Klaus; Paatero, Ilkka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies (2025)

Molecular Oncology

Ojala, Veera K.; Ahonen, Sini; Peltola, Sara; Tuohisto-kokko, Aura; Esparta, Olaya; Suominen, Peppi; Jokilammi, Anne; Farahani, Iman; Chakroborty, Deepankar; Dibus, Nikol; Boettcher, Steffen; Airenne, Tomi T.; Johnson, Mark S.; Eli, Lisa D.; Elenius, Klaus; Kurppa, Kari J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Indignity of Nazi data: reflections on the utilization of illicit research (2024)

Medicine, Health Care and Philosophy

Farahani, Iman; Janhonen, Joel

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Iman

Farahani

Contact

Publications

Sort by:

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB‐inhibitor‐induced phenotypes (2025)

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies (2025)

Indignity of Nazi data: reflections on the utilization of illicit research (2024)